The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The Neurosteroid Tetrahydroprogesterone Attenuates the Endocrine Response to Stress and Exerts Glucocorticoid-like Effects on Vasopressin Gene Transcription in the Rat Hypothalamus
Abstract
The neurosteroid tetrahydroprogesterone (5 alpha-pregnan-3 alpha-ol-20-one, allopregnanolone, THP), has been previously shown to counteract the anxiogenic effects of corticotropin-releasing hormone (CRH) and to interfere with noradrenergic and corticosteroid-mediated regulation of CRH release and gene transcription. Those observations indicated that, besides its sedative and analgesic activity, THP may also affect the neuroendocrine response to stress in a mode resembling that of corticosteroids. To examine this possibility, we compared the ability of THP, its precursor progesterone (P4), and the glucocorticoids dexamethasone (DEX) and corticosterone (CORT) to influence the pituitary-adrenal response to acute emotional stress and the adrenalectomy-induced increase in the gene transcription of the stress-related peptide arginine vasopressin (AVP) and of corticosteroid receptors (MR and GR) in the brain. Pretreatment of rats with a single dose of THP or P4 (50 micrograms/kg) significantly attenuated the elevation of plasma adrenocorticotropin (ACTH) and serum corticosterone after emotional stress; both steroids were, however, less potent than a similar dose of DEX. Administration of 1 mg of THP, CORT, or P4 to adrenalectomized (ADX) rats attenuated the increase in AVP mRNA levels in the ventromedial subdivision of the hypothalamic paraventricular nucleus (PVN), as compared with vehicle-treated ADX rats. However, whereas CORT and P4 influenced the ADX-induced increase in the transcription of both types of corticosteroid receptors in the hippocampus, these were unaffected by THP. In contrast to the glucocorticoids, THP and P4 failed to decrease plasma ACTH levels in rats deprived of endogenous steroids. These results demonstrate that the neurosteroid THP and its precursor P4 resemble glucocorticoids in their suppression of the pituitary-adrenal response to emotional stress; however, THP influences the transcription of glucocorticoid-responsive genes in brain structures involved in the regulation of the hypothalamo-pituitary-adrenal system in a fashion that is quite distinct from that obtained with glucocorticoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Allopregnanolone has induced the GABAergic inhibition of HPA axis activation in female rats [93,94] and pregnant women [95].”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [93]
In the citing paper
“another potent GABAA receptor modulator and deoxycorticosterone-derived steroid, tetrahydrodeoxycorticosterone (TH-DOC), also attenuates the HPA axis function (77, 82, 83).”
From Higher Circulating Cortisol in the Follicular vs. Luteal Phase of the Menstrual Cycle: A Meta-Analysis (2020) · cites this paper as [83]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965
Purdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Cited by
Sorted by citations
Items 101–200 of 259
Romeo, R., Bellani, R., & McEwen, B. (2005) · Stress · doi:10.1080/10253890500489320 · Cited by 59
“…progesterone is a precursor to many neuroactive steroids produced in the nervous system that also have a myriad of neurophysiological and behavioural effects (Oettel and Mukhopadhyay 2004), including modulation of the HPA axis (Patchev et al. 1994; Patchev and Almeida 1996; Patchev et al. 1996).”
BackgroundThe Relevance of Neuroactive Steroids in Schizophrenia, Depression, and Anxiety Disorders
MacKenzie, E. M., Odontiadis, J., Mellédo, J. L., Prior, T. I., & Baker, G. B. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9086-0 · Cited by 61
“It has been reported that ALLO administration attenuates the ACTH and CORT response to emotional stress in rats (Patchev et al., 1996).”
BackgroundPierucci‐Lagha, A., Covault, J., Feinn, R., Khisti, R. T., Morrow, A. L., Marx, C. E., Shampine, L. J., & Kranzler, H. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0231-0 · Cited by 62
“They also attenuate stress responses mediated by the hypothalamic pituitary adrenal axis (Owens et al. 1992; Patchev et al. 1994, 1996).”
BackgroundSze, Y., Gill, A. C., & Brunton, P. J. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12644 · Cited by 69
“12,13 Despite these findings, it is not known whether there are sex differences in the stress‐induced neuroactive steroid con‐ centrations in the brain, which could potentially contribute to the differential HPA axis responses in males and females.”
BackgroundFrye, C. A., & Rhodes, M. E. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01494.x · Cited by 58
Neuroactive steroids as modulators of depression and anxiety
Eser, D., Romeo, E., Baghai, T. C., di Michele, F., Schüle, C., Pasini, A., Zwanzger, P., Padberg, F., & Rupprecht, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.007 · Cited by 54
Rasmusson, A. M., & Pineles, S. L. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0908-9 · Cited by 63
Reduced Hypothalamo‐pituitary‐adrenal Axis Stress Responses in Late Pregnancy
Russell, J. A., Douglas, A. J., & Brunton, P. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.032 · Cited by 52
Paris, J. J., Zou, S., Hahn, Y. K., Knapp, P. E., & Hauser, K. F. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.01.007 · Cited by 47
Reconsidering GHB: orphan drug or new model antidepressant?
Bosch, O. G., Quednow, B. B., Seifritz, E., & Wetter, T. C. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111421975 · Cited by 49
Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice
Frye, C. A., & Llaneza, D. C. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.005 · Cited by 52
Mensah‐Nyagan, A. G., Beaujean, D., Luu-The, V., Pelletier, G., & Vaudry, H. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00110-2 · Cited by 50
Effects of acute progesterone administration upon responses to acute psychosocial stress in men.
Childs, E., Dam, N. T. V., & de Wit, H. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0018060 · Cited by 55
“The University of Chicago Medical Endocrinology Laboratory determined levels of ACTH and progesterone in plasma (Immulite 2000 Progesterone, sensitivity 0.1 ng/ml).”
InfluentialBrunton, P. J. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02067.x · Cited by 43
Rego, J. D., Mensah-Nyagan, A., Beaujean, D., Leprince, J., Tonon, M., Luu-The, V., Pelletier, G., & Vaudry, H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00053.x · Cited by 50
Neurosteroids: non-genomic pathways in neuroplasticity and involvement in neurological diseases
Schverer, M., Lanfumey, L., Baulieu, É.-É., Froger, N., & Villey, I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.011 · Cited by 59
Brunton, P. J., & Russell, J. A. (2010) · Stress · doi:10.3109/10253890.2010.482628 · Cited by 55
“Moreover, mimicking pregnancy in virgin rats with short-term (20 h) AP treatment attenuates stressinduced HPA axis activity (Figure 1b; Brunton et al. 2009), consistent with studies in male rats (Patchev et al. 1996).”
BackgroundResultNeurophysiological and cognitive changes in pregnancy
Grattan, D. R., & Ladyman, S. R. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64239-4.00002-3 · Cited by 70
Neuroactive steroids and stress axis regulation: Pregnancy and beyond
Brunton, P. J. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.08.003 · Cited by 48
do Rego, J. L., Tremblay, Y., Luu‐The, V., Repetto, E., Castel, H., Vallarino, M., Bélanger, A., Pelletier, G., & Vaudry, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04209.x · Cited by 50
Wilson, M. E., Legendre, A., Pazol, K., Fisher, J., & Chikazawa, K. (2005) · Endocrine · doi:10.1385/endo:26:2:089 · Cited by 46
Vasotocin and Mesotocin Stimulate the Biosynthesis of Neurosteroids in the Frog Brain
Do‐Régo, J., Acharjee, S., Seong, J. Y., Galas, L., Alexandre, D., Bizet, P., Burlet, A. J., Kwon, H. B., Luu-The, V., Pelletier, G., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4469-05.2006 · Cited by 48
“…to novelty, aggressiveness, anxiety, depression, stress, learning and memory, sexual behavior, locomotion, body temperature, and blood pressure (Patchev et al., 1996; Baulieu et al., 1999; Rupprecht and Holsboer, 1999; Compagnone and Mellon, 2000; Vallée et al., 2000, 2001; Bernardi et al.,…”
Neuroendocrine pathways underlying risk and resilience to PTSD in women
Ravi, M., Stevens, J. S., & Michopoulos, V. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100790 · Cited by 57
Frye, C. A., Paris, J. J., Walf, A. A., & Rusconi, J. C. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00136 · Cited by 40
“3α,5α-THP has central actions to dampen HPA para/sympathetic physiological responses, in addition to its anxiolytic psychological effects (Patchev et al., 1994, 1996).”
BackgroundRole of progesterone and other neuroactive steroids in anxiety disorders
Mellédo, J. L., & Baker, G. B. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.5.851 · Cited by 45
Schaeffer, V., Patte‐Mensah, C., Eckert, A., & Mensah‐Nyagan, A. G. (2006) · Journal of Neurobiology · doi:10.1002/neu.20267 · Cited by 48
Neuroactive steroids and anxiety disorders.
Melledo, J. L., & Baker, G. (2002) · Journal of Psychiatry & Neuroscience · doi:10.1139/jpn.0219 · Cited by 44
“For example, peripheral administration of ALLO and 3α,5α-THDOC to rats dampened the activity of the HPA axis in response to stress.(26,27) Subcutaneous administration of ALLO lessened the release of corticosterone in response to air puffs (a stress test) in adult male rats and decreased gene transcription of arginine…”
Concas, A., Porcu, P., Sogliano, C., Serra, M., Purdy, R., & Biggio, G. (2000) · Pharmacology, Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00237-9 · Cited by 44
Mechlin, B., Morrow, L., Maixner, W., & Girdler, S. (2007) · Pain · doi:10.1016/j.pain.2006.12.027 · Cited by 43
“, 2006), and ALLO modulates the HPA-axis at multiple levels (Owens et al., 1992; Patchev et al., 1994; Patchev et al., 1996; Calogero et al., 1998), higher circulating ALLO would be expected to be associated with increased pain sensitivity as we documented in the non-Hispanic Whites.”
BackgroundInfluentialSchumacher, M., Guennoun, R., Mattern, C., Oudinet, J., Labombarda, F., Nicola, A. F. D., & Lière, P. (2015) · Steroids · doi:10.1016/j.steroids.2015.08.013 · Cited by 47
“By restoring the GABAergic tone after stress, they may moderate the activation of the hypothalamo-pituitaryadrenal (HPA) axis, the major neuroendocrine stress response system, and exert anxiolytic, analgesic and anticonvulsant actions [113, 116-118].”
BackgroundAllopregnanolone modulation of HPA axis function in the adult rat
Biggio, G., Pisu, M. G., Biggio, F., & Serra, M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3521-6 · Cited by 40
“Allopregnanolone also exerted a potent inhibitory action on HPA axis activity and attenuated the elevation of plasma ACTH and corticosterone elicited by stress (Patchev et al. 1996), an effect similar to that induced by benzodiazepines (Imaki et al.”
ResultFreitas-de-Melo, A., Banchero, G., Hötzel, M., Damián, J. P., & Ungerfeld, R. (2013) · Animal · doi:10.1017/s1751731113000621 · Cited by 40
“In rats, these metabolites provoke a decrease in corticotropin-releasing hormone mRNA expression, and thus the secretion of adrenocorticotropic hormone and glucocorticoids, reducing the physiological (Patchev et al., 1996; Barbaccia et al., 2001; Brunton et al., 2009) and behavioural (Bitran et al.”
BackgroundCook, J. B., Dumitru, A. M. G., O’Buckley, T. K., & Morrow, A. L. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12223 · Cited by 43
“GABAergic neuroactive steroids contribute to negative feedback on the HPA axis at the level of the hypothalamus in rats (Owens et al., 1992; Patchev et al., 1994; Patchev et al., 1996), but not in C57BL/6J mice (Sarkar et al.”
BackgroundRegulation of Neurosteroid Biosynthesis by Neurotransmitters and Neuropeptides
do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Vaudry, D., Luu-The, V., Tonon, M., Tsutsui, K., Pelletier, G., & Vaudry, H. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00004 · Cited by 45
“…al., 2003; van Broekhoven and Verkes, 2003), anti-aggressive (Kavaliers and Kinsella, 1995; Pinna et al., 2008), hypnotic (Lancel et al., 1997; Damianisch et al., 2001), anti-convulsive (Landgren et al., 1987; Belelli et al., 1989), and anti-stress actions (Patchev et al., 1996; Hu et al., 2000).”
Segebladh, B., Bannbers, E., Moby, L., Nyberg, S., Bixo, M., Bäckström, T. C., & Poromaa, I. S. (2013) · Archives of Women s Mental Health · doi:10.1007/s00737-013-0327-1 · Cited by 38
“While most studies have suggested a negative modulation, i.e., allopregnanolone administration dampens the stress-induced cortisol increase (Guo et al. 1995; Patchev et al. 1996), few attempts have been made to elucidate allopregnanolone influences on diurnal variation.”
BackgroundPremenstrual syndrome, neuroactive steroids and the brain.
Sundström, I., Bäckström, T., Wang, M.-D., Olsson, T., Seippel, L., & Bixo, M. (1999) · Gynecological Endocrinology · doi:10.3109/09513599909167557 · Cited by 39
Porcu, P., & Morrow, A. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3564-8 · Cited by 41
“Moreover, 3α,5α-THP or 3α,5α-THDOC administration before stress attenuates the stress-induced increase in ACTH and corticosterone in Wistar rats (Owens et al. 1992; Patchev et al. 1996).”
Paris, J. J., Walf, A. A., & Frye, C. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.099 · Cited by 38
“In particular, 3α,5α-THP is demonstrated to dampen HPA activity (Patchev et al., 1996), reduce cell death and promote positive prognosis in models of brain injury/degeneration (Baulieu and Schumacher, 2000; Frye, 2009; Sayeed and Stein, 2009), and improve cognitive status in healthy models and models of neurodegenerat…”
BackgroundDanovich, L., Veenman, L., Leschiner, S., Lahav, M., Ben-Yosef, V. S., Weizman, A., & Gavish, M. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.04.005 · Cited by 38
Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders
Eser, D., Schüle, C., Romeo, E., Baghai, T. C., di Michele, F., Pasini, A., Zwanzger, P., Padberg, F., & Rupprecht, R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0188-z · Cited by 39
“These neuroactive steroids in turn decreased the stress-induced corticosterone release (Owens et al. 1992; Patchev et al. 1996).”
BackgroundChapter 3 Hormonal Influences on Seizures
Frye, C. (2008) · International review of neurobiology · doi:10.1016/s0074-7742(08)00003-2 · Cited by 35
Porcu, P., Rogers, L. S. M., Morrow, A. L., & Grant, K. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.004 · Cited by 33
Zimmerberg, B., Rackow, S. H., & George-Friedman, K. P. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00149-5 · Cited by 32
Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature
McEvoy, K., Payne, J. L., & Osborne, L. M. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0937-4 · Cited by 35
Patchev, V. K., Hayashi, S., Orikasa, C., & Almeida, O. F. X. (1999) · Stress · doi:10.3109/10253899909001111 · Cited by 32
Self-citationFrye, C., Paris, J. J., & Rhodes, M. E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.005 · Cited by 33
“Further, administration of 3α,5α-THP reduces stress-induced elevations in adrenocorticotropin and corticosterone [60].”
BackgroundMathieu, M., Mensah‐Nyagan, A. G., Vallarino, M., do Rego, J. L., Beaujean, D., Vaudry, D., Luu‐The, V., Pelletier, G., & Vaudry, H. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1304 · Cited by 35
Neuroactive steroids in neuropsychopharmacology.
Rupprecht, R., & Holsboer, F. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46072-7 · Cited by 31
Neurosteroid influences on sensitivity to ethanol
Helms, C. M., Rossi, D. J., & Grant, K. A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00010 · Cited by 30
“A recent report indicated that physiological concentrations of allopregnanolone, THDOC, and pregnenolone in cell culture inhibited CRH reporter gene activity and forskolin-stimulated transcription (Budziszewska et al., 2010).”
BackgroundInfluentialPisu, M. G., Garau, A., Olla, P., Biggio, F., Utzeri, C., Dore, R., & Serra, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12273 · Cited by 29
Baby on board: Do responses to stress in the maternal brain mediate adverse pregnancy outcome?
Douglas, A. J. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.05.002 · Cited by 28
Frye, C., Paris, J. J., & Rhodes, M. E. (2008) · Reproduction · doi:10.1530/rep-08-0250 · Cited by 29
The anxiolytic effect of pregnancy in rats is reversed by finasteride.
Faturi, C. D. B., Teixeira-Silva, F., & Leite, J. (2006) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.011 · Cited by 29
Leão, L. L., Miri, S., & Hammami, R. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101173 · Cited by 29
“This heightened HPA axis activity in response to estradiol may explain the higher rates of anxiety and depression observed in women (Oyola and Handa, 2017; Patchev, 1996).”
Anne, I., Charlotte, L., & Alan, J. (2012) · InTech eBooks · doi:10.5772/25611 · Cited by 22
Lee, E., Nieman, L. K., Martinez, P. E., Harsh, V., Rubinow, D. R., & Schmidt, P. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3451 · Cited by 26
Ray, L. A., Hutchison, K. E., Ashenhurst, J. R., & Morrow, A. L. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01233.x · Cited by 24
Walf, A. A., & Frye, C. A. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00040 · Cited by 26
“Together, these data further provide evidence supporting a role of neurosteroids as modulators of the HPA (Purdy et al., 1991; Patchev et al., 1994, 1996; Guo et al., 1995).”
BackgroundLeggio, L., Cardone, S., Ferrulli, A., Kenna, G. A., Diana, M., Swift, R. M., & Addolorato, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791516369 · Cited by 26
“Endogenous steroids have anxiolytic, anticonvulsant, analgesic and hypnotic properties, and also attenuate stress responses mediated by the HPA axis [351].”
BackgroundThe 3β-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in mice
Espallergues, J., Givalois, L., Temsamani, J., Laruelle, C., & Maurice, T. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.11.003 · Cited by 26
Porcu, P., Grant, K. A., Green, H. L., Rogers, L. S. M., & Morrow, A. L. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0132-2 · Cited by 27
“Likewise, GABAergic neuroactive steroids inhibit CRF production and release, ACTH release, and subsequent corticosterone levels in rodents (Owens et al. 1992; Patchev et al. 1994, 1996).”
BackgroundRhodes, M. E., McCormick, C. M., & Frye, C. A. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.04.021 · Cited by 26
Gatta, E., Camussi, D., Auta, J., Guidotti, A., & Pandey, S. C. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108299 · Cited by 28
Kohtz, A. S., Paris, J. J., & Frye, C. A. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.02.005 · Cited by 28
“Some of these effects may be due in part to central modulation of 3α,5α-THP which can act in hypothalamus to attenuate neuroendocrine responses to a stressor and restore homeostasis (Patchev et al., 1994, 1996).”
BackgroundBeckley, E. H., Fretwell, A. M., Tanchuck, M. A., Gililland, K. R., Crabbe, J. C., & Finn, D. A. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.006 · Cited by 23
“…ALLO pre-treatment to decrease plasma corticosterone levels may be due to the anxiolytic effect of this steroid (e.g., Akwa et al., 1999; Bitran et al., 1991, 1999; Finn et al., 1997) and/or the ability of ALLO to decrease the stress-induced increase in HPA axis activation (Patchev et al., 1996).”
BackgroundNeurosteroids – From Basic Research to Clinical Perspectives
Frye, C. A. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00086-3 · Cited by 24
How is prenatal stress transmitted from the mother to the fetus?
Sze, Y., & Brunton, P. J. (2024) · Journal of Experimental Biology · doi:10.1242/jeb.246073 · Cited by 31
Ren, P., Ma, L., Wang, J.-Y., Guo, H., Sun, L. J., Gao, M., Liu, Y., Ma, Y., Li, Y., & Guo, W.-Z. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03036-9 · Cited by 25
Giving a good start to a new life via maternal brain allostatic adaptations in pregnancy
Russell, J. A., & Brunton, P. J. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.02.003 · Cited by 24
Brunton, P. J., Donadio, M. V. F., Yao, S. T., Greenwood, M., Seckl, J. R., Murphy, D., & Russell, J. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5104-13.2015 · Cited by 48
Nieminen, L. R., Makino, K. K., Mehta, N., Virkkunen, M., Kim, H.-Y., & Hibbeln, J. R. (2006) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.07.012 · Cited by 23
“3a,5aTHP and THDOC potentiate GABAA receptor inhibition of the central nervous system [8] and have several anxiolytic properties [17,18] including: counteraction of the down regulated GABA receptor function observed in acute stress [19], decreased dopamine metabolism in prefrontal cortex [20], decreased gene expressio…”
BackgroundThe Allopregnanolone Response to Acute Stress in Females: Preclinical and Clinical Studies
Pisu, M. G., Concas, L., Siddi, C., Serra, M., & Porcu, P. (2022) · Biomolecules · doi:10.3390/biom12091262 · Cited by 20
“Such elevations in allopregnanolone levels exert negative feedback upon the HPA axis, thus reducing the neuroendocrine response to stress by inhibiting CRH production and release, ACTH release, and the subsequent corticosterone increase in rats subjected to acute stress [15,16].”
BackgroundBiggio, F., Talani, G., Locci, V., Pisu, M. G., Boero, G., Ciarlo, B., Grayson, D. R., & Serra, M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.005 · Cited by 20
“, 1995), exerts a potent inhibitory action on HPA axis activity attenuating the increase of plasma ACTH and corticosterone elicited by stress (Bali and Jaggi, 2014; Biggio et al., 2004a; Rupprecht and Holsboer, 1999; Patchev et al. 1996).”
Progesterone reduces hyperactivity of female and male dopamine transporter knockout mice
Frye, C. A., & Sora, I. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.015 · Cited by 21
Morrow, A. L., Biggio, G., Serra, M., Becker, H. C., Lopez, M. F., Porcu, P., Alward, S. E., & O’Buckley, T. K. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.04.002 · Cited by 21
“Likewise, GABAergic neuroactive steroids inhibit CRF production, release, ACTH release and subsequent corticosterone levels in rodents (Owens et al., 1992; Patchev et al., 1996; Patchev et al., 1994).”
Marx, C., Naylor, J., Kilts, J., Dunn, C. E., Tupler, L. A., Szabo, S., Capehart, B., Morey, R., Shampine, L. J., & Acheson, S. (2016) · doi:10.1201/b18959-8 · Cited by 21
Auger, C. J., & Vanzo, R. J. (2005) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01400.x · Cited by 21
Neurosteroids for a successful pregnancy
Frye, C. A., Hirst, J. J., Brunton, P. J., & Russell, J. A. (2010) · Stress · doi:10.3109/10253890.2010.540050 · Cited by 19
“As such, neurosteroids like allopregnanolone have important benzodiazepine-like actions that are associated with reductions in stress responding and restoration of HPA homeostasis (Patchev et al. 1996; Barbaccia et al. 2001).”
BackgroundBarbaccia, M. L., Scaccianoce, S., Bianco, P. D., Campolongo, P., Trezza, V., Tattoli, M., Cuomo, V., & Steardo, L. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.06.013 · Cited by 19
Early postnatal stimulation alters pregnane neurosteroids in the hippocampus
Frye, C., Rhodes, M. E., Raol, Y. H., & Brooks-Kayal, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0253-7 · Cited by 20
“…attribute causal effects of altered 3α,5α-THP levels on corticosterone levels from the present data, previous reports show that the administration of 3α,5α-THP significantly attenuates elevation of plasma ACTH and serum corticosterone following exposure to emotional stress (Patchev et al. 1996).”
ResultInfluentialEgan, A. E., Thompson, A. M. K., Buesing, D., Fourman, S. M., Packard, A. E. B., Terefe, T., Li, D., Wang, X., Song, S., Solomon, M. B., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.05.030 · Cited by 19
Girdler, S. S., Mechlin, B., Light, K. C., & Morrow, A. L. (2006) · Psychophysiology · doi:10.1111/j.1469-8986.2006.00410.x · Cited by 18
Stress and cytokine effects on learning: What does sex have to do with it?
Beck, K. D., & Servatius, R. J. (2003) · Integrative Psychological and Behavioral Science · doi:10.1007/bf02688852 · Cited by 16
Die Neuroendokrinologie von Stress und die Pathophysiologie und Therapie von Depression und Angst
Ströhle, A. (2003) · Der Nervenarzt · doi:10.1007/s00115-002-1444-7 · Cited by 18
Microbiota modulates the steroid response to acute immune stress in male mice
Vagnerová, K., Gazárková, T., Vodička, M., Ergang, P., Klusoňová, P., Hudcovic, T., Šrůtková, D., Hermanová, P. P., Nováková, L., & Pácha, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1330094 · Cited by 18
Duffy, K. A., Harris, L. T., Chartrand, T. L., & Stanton, S. J. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.017 · Cited by 18
“…of progesterone into allopregnanolone, a powerful anxiolytic that reduces stress in two ways: (1) by acting on GABA receptors in the brain and (2) by downregulating gene transcription for corticotrophin-releasing hormone in the HPA axis (Bitran et al., 1995, 1993; Patchev et al., 1996, 1994).”
BackgroundPorcu, P., O’Buckley, T. K., Morrow, A. L., & Adinoff, B. H. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.11.003 · Cited by 20
“Likewise, the GABAergic neuroactive steroids inhibit CRH production, ACTH release and corticosterone increase in rodents (Owens et al., 1992; Patchev et al., 1994; Patchev et al., 1996).”
BackgroundIntergenerational Perioperative Neurocognitive Disorder
Ju, L.-S., Morey, T. E., Seubert, C. N., & Martynyuk, A. E. (2023) · Biology · doi:10.3390/biology12040567 · Cited by 18
“GABA type A receptor (GABAAR)-mediated control of the CRH-releasing PVN neurons is another important mechanism regulating the HPA axis [83,104,105].”
BackgroundFrye, C. A., Paris, J. J., Osborne, D. M., Campbell, J. C., & Kippin, T. E. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00052 · Cited by 18
Bethea, C. L., & Centeno, M. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301442 · Cited by 17
“In rodents, allopregnanolone attenuated endocrine responses to stress (Patchev et al, 1996) and progesterone, via conversion into allopregnanalone, attenuated CRH-enhanced startle (Toufexis et al, 2004).”
BackgroundBasta‐Kaim, A., Budziszewska, B., Jaworska-Feil, L., Leśkiewicz, M., Tetich, M., Otczyk, M., Kubera, M., & Lasoń, W. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.02.004 · Cited by 18
Maternal Brain Adaptations in Pregnancy
Brunton, P. J., & Russell, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00044-2 · Cited by 18
Frye, C. A., Paris, J. J., & Rhodes, M. E. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.018 · Cited by 16
“In support, administration of systemic 3α,5α-THP reduces ACTH levels in response to intermittent air-puff exposure (Patchev et al., 1996).”
BackgroundAuger, C. J., Jessen, H. M., & Auger, A. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.10.033 · Cited by 14
The role of neuroactive steroids in tic disorders
Branca, C., & Bortolato, M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105637 · Cited by 21
Boero, G., Tyler, R. E., Todd, C. A., O’Buckley, T. K., Balan, I. S., Besheer, J., & Morrow, A. L. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108463 · Cited by 16
Sze, Y., & Brunton, P. J. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12916 · Cited by 18
Inslicht, S. S., Richards, A. L., Madden, E., Rao, M. N., O’Donovan, A., Talbot, L. S., Rucker, E., Metzler, T. J., Hauger, R. L., & Neylan, T. C. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3621-3 · Cited by 17
Valeš, K., Rambousek, L., Holubová, K., Svoboda, J., Bubeníková-Valešová, V., Chodounská, H., Vyklický, L., & Stuchlík, A. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.020 · Cited by 15
Role of progestins with partial antiandrogenic effects
Sitruk-Ware, R. L., Husmann, F., Thijssen, J. H. H., Skouby, S. O., Fruzzetti, F., Hanker, J. P., Huber, J., & Druckmann, R. A. (2004) · Climacteric · doi:10.1080/13697130400001307 · Cited by 15
Metadata
- Authors
- Patchev, V
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Patchev, V
- Venue
- Neuropsychopharmacology
- Published
- 1996-12
- Volume
- 15
- Issue
- 6
- Pages
- 533-540
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W2072990514
- Cited by
- 283
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 10 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 10 · 2017: 3 · 2016: 10 · 2015: 6 · 2014: 16 · 2013: 12 · 2012: 11
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Max-Planck-Gesellschaft
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- tetrahydroprogesterone, allopregnanolone, neurosteroids, progesterone, pituitary-adrenal response, emotional stress, vasopressin, paraventricular nucleus, corticosteroid receptors, mineralocorticoid receptor, glucocorticoid receptor, ACTH, corticosterone, dexamethasone, adrenalectomy, hypothalamus
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Anti-Inflammatory Agents, Arginine Vasopressin, Corticosterone, Dexamethasone, Glucocorticoids, Hypothalamus, Male, Pregnanolone, Progesterone, Receptors, Steroid, Stress, Psychological, Anti-Anxiety Agents, Transcription, Genetic, Rats, Wistar, Neuroprotective Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review